Fiji vs Malta: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Malta
100.0%
in 2022
Fiji rank
1st
Malta rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Malta
How they compare
Fiji currently reports 100.0% against 100.0% in Malta, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 2007 it was Malta ahead.
Fiji ranks 1st and Malta ranks 1st of 180 countries.
Across the 3 decades both report, Fiji averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Fiji | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 0.0% | 50.0% | Fiji |
| 2010s | 12.1% | 66.8% | 54.7% | Malta |
| 2020s | 8.8% | 100.0% | 91.2% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Malta?
- Fiji, at 100.0% against 100.0% in Malta as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Malta?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Malta?
- 7 years are reported by both, from 2007 to 2022.
- How do Fiji and Malta rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Malta ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.